Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum

Updated on: May 21,2024

Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum

Updated on:May 21,2024

Keeping aggressive cancer cells in check by blocking a protein responsible for repairs

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained

Updated on: January 07,2024

Keeping aggressive cancer cells in check by blocking a protein responsible for repairs

by Catarina Pietschmann,Max Delbrück Center for Molecular MedicineThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained

Updated on:January 07,2024

Largest study of its kind reveals adjuvant chemotherapy improves overall survival for pancreatic cancer patients

byCU Anschutz Medical CampusCredit: CC0 Public DomainToday, the University of Colorado Cancer Center released new research that showcases chemotherapy treatment before and after surgery for panc

Updated on: January 07,2024

Largest study of its kind reveals adjuvant chemotherapy improves overall survival for pancreatic cancer patients

byCU Anschutz Medical CampusCredit: CC0 Public DomainToday, the University of Colorado Cancer Center released new research that showcases chemotherapy treatment before and after surgery for panc

Updated on:January 07,2024

Trial results show PARP inhibitor benefit in 'BRCA-like' breast cancer

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free surviva

Updated on: January 04,2024

Trial results show PARP inhibitor benefit in 'BRCA-like' breast cancer

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free surviva

Updated on:January 04,2024

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Updated on: July 08,2024

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Updated on:July 08,2024

People with type 2 diabetes at higher risk of certain cancers could be identified by a simple blood test, study suggests

byDiabetologiaCredit: Karolina Grabowska from PexelsIndividuals with type 2 diabetes who are at higher risk of certain cancers could be identified by a simple blood test, this year'sAn

Updated on: September 07,2024

People with type 2 diabetes at higher risk of certain cancers could be identified by a simple blood test, study suggests

byDiabetologiaCredit: Karolina Grabowska from PexelsIndividuals with type 2 diabetes who are at higher risk of certain cancers could be identified by a simple blood test, this year'sAn

Updated on:September 07,2024

Immune evasion tactics of liver cancer cells revealed

byeLifeActivated ß-catenin represses immune infiltration in liver cancer spheroids through exosomes. (a) Peripheral Blood Mononuclear Cells (PBMC) infiltration analysis protocol. Created with Bi

Updated on: March 30,2024

Immune evasion tactics of liver cancer cells revealed

byeLifeActivated ß-catenin represses immune infiltration in liver cancer spheroids through exosomes. (a) Peripheral Blood Mononuclear Cells (PBMC) infiltration analysis protocol. Created with Bi

Updated on:March 30,2024

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de

Updated on: February 18,2024

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de

Updated on:February 18,2024

Small risks may have big impact on breast cancer odds of childhood cancer survivors

bySt. Jude Children's Research HospitalZhaoming Wang, Ph.D., used data from the St. Jude Lifetime Cohort study to find evidence that common genetic variations can help to identify pediatric

Updated on: December 18,2023

Small risks may have big impact on breast cancer odds of childhood cancer survivors

bySt. Jude Children's Research HospitalZhaoming Wang, Ph.D., used data from the St. Jude Lifetime Cohort study to find evidence that common genetic variations can help to identify pediatric

Updated on:December 18,2023

Identifying the underlying causes of ovarian cancer

byCedars-Sinai Medical CenterSimon Gayther, PhD, professor of Biomedical Sciences, and Michelle Jones, PhD, a research scientist in the Center for Bioinformatics and Functional Genomics, led the

Updated on: January 02,2024

Identifying the underlying causes of ovarian cancer

byCedars-Sinai Medical CenterSimon Gayther, PhD, professor of Biomedical Sciences, and Michelle Jones, PhD, a research scientist in the Center for Bioinformatics and Functional Genomics, led the

Updated on:January 02,2024

A new tool for diagnosing cancer: Platform combines structural details with molecular information about a tumor

by Harvard Medical SchoolThe Orion tool combines molecular details revealed by immunofluorescence imaging (left) with structural information gained through traditional histology staining (middle)

Updated on: February 24,2024

A new tool for diagnosing cancer: Platform combines structural details with molecular information about a tumor

by Harvard Medical SchoolThe Orion tool combines molecular details revealed by immunofluorescence imaging (left) with structural information gained through traditional histology staining (middle)

Updated on:February 24,2024

COVID vaccination improves effectiveness of cancer treatment, study finds

byUniversity of BonnNasopharyngeal tumors (highlighted in yellow) - are a common condition in countries in Southeast Asia. However, concerns that the therapy might interact unfavorably with Covi

Updated on: January 23,2024

COVID vaccination improves effectiveness of cancer treatment, study finds

byUniversity of BonnNasopharyngeal tumors (highlighted in yellow) - are a common condition in countries in Southeast Asia. However, concerns that the therapy might interact unfavorably with Covi

Updated on:January 23,2024